Boothbay Fund Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Boothbay Fund Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Hold	357,447	–	–	﹤0.01%	1988
2026 Q1	$313K	Hold	357,447	–	–	﹤0.01%	1589
2025 Q4	$654K	Hold	357,447	–	–	0.01%	998
2025 Q3	$851K	Buy	+357,447	New	+$30.4K	0.01%	902
2021 Q1	–	Sell	-24,622	Closed	-$246K	–	1659
2020 Q4	$246K	Hold	24,622	–	–	0.01%	1024
2020 Q3	$244K	Sell	24,622 -5,678	-19%	-$5.74K	0.01%	872
2020 Q2	$311K	Buy	+30,300	New	+$18.9K	0.02%	690

Other funds holding JSPRW

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's JSPRW Position: Q2 2026 in Review

Boothbay Fund Management held its Japer Therapeutics Warrants (JSPRW) position steady in Q2 2026 at 357,447 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Boothbay Fund Management first reported a position in JSPRW in Q2 2020 and has held it in 7 quarters since. The position peaked at $851K in Q3 2025. 6 funds tracked by Wall St. Rank hold JSPRW as of Q2 2026.

Boothbay Fund Management held 357,447 shares of Japer Therapeutics Warrants worth $150K as of Q2 2026.
Boothbay Fund Management left its Japer Therapeutics Warrants share count unchanged in Q2 2026.
Japer Therapeutics Warrants made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1988 holding.
Boothbay Fund Management first reported a position in Japer Therapeutics Warrants in Q2 2020 and has held it in 7 quarters since.
Boothbay Fund Management's Japer Therapeutics Warrants position peaked at $851K in Q3 2025.
6 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.